Evidence map›Paper›PMID 36000040›Full record

ArticleLaryngoscope investigative otolaryngology2022

Immunohistochemical localization of d-

Shiori Kitaya, Ryoukichi Ikeda, Jun Suzuki, Hidetoshi Oshima, Yuri Nomura, Yusuke Kusano, Nobuo Ohta, Tetsuaki Kawase, Kazue Ise, Kazuhiro Murakami and 3 more

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Correction to "Immunohistochemical localization of d-Laryngoscope investigative otolaryngology · 2023
    Article
  2. Immunohistochemical localization of d-Laryngoscope investigative otolaryngology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Shiori KitayaDepartment of Otolaryngology, Head and Neck Surgery Tohoku University Hospital Sendai Japan.ORCID https://orcid.org/0000-0002-7238-1338
Ryoukichi IkedaDepartment of Otolaryngology, Head and Neck Surgery Tohoku University Hospital Sendai Japan.ORCID https://orcid.org/0000-0003-0076-6092
Jun SuzukiDepartment of Otolaryngology, Head and Neck Surgery Tohoku University Hospital Sendai Japan.
Hidetoshi OshimaCenter for Otologic Surgery Sen-en Rifu Hospital Rifu Miyagi Japan.
Yuri NomuraCenter for Otologic Surgery Sen-en Rifu Hospital Rifu Miyagi Japan.
Yusuke KusanoDepartment of Otolaryngology, Head and Neck Surgery Tohoku University Hospital Sendai Japan.
Nobuo OhtaDivision of Otolaryngology Tohoku Medical and Pharmaceutical University Hospital Sendai Japan.ORCID https://orcid.org/0000-0002-2821-6976
Tetsuaki KawaseDepartment of Otolaryngology, Head and Neck Surgery Tohoku University Hospital Sendai Japan.
Kazue IseTechnical Services Division Tohoku Medical and Pharmaceutical University Sendai Japan.
Kazuhiro MurakamiDivision of Pathology Tohoku Medical and Pharmaceutical University Hospital Sendai Japan.
Yasuhiro NakamuraDivision of Pathology Tohoku Medical and Pharmaceutical University Hospital Sendai Japan.
Hironobu SasanoDepartment of Pathology Tohoku University School of Medicine Sendai Japan.
Yukio KatoriDepartment of Otolaryngology, Head and Neck Surgery Tohoku University Hospital Sendai Japan.
Senshio Rifu hospital · JPTohoku University Hospital · JPTohoku Medical and Pharmaceutical University Hospital · JPTohoku Medical and Pharmaceutical University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective/Hypothesis: Middle ear cholesteatoma is characterized by abnormal growth of the keratinizing squamous epithelium of the temporal bone. d- Study Design: Case-control studies. Material and Methods: Tissue samples were collected from 21 patients comprising 21 ears with congenital middle ear cholesteatoma and 26 patients comprising 29 ears with acquired type. Their clinical and histopathological features were investigated. We divided the middle ear cholesteatoma samples into three layers: the perimatrix, matrix, and cystic contents. The patterns of immunoreactivity to d- Results: Two patterns of immunoreactivity to d- Conclusions: This study showed the expression levels of d- Level of Evidence: 4.

Indexed as

acquired middle ear cholesteatomacongenital middle ear cholesteatomad‐β‐aspartic acidmatrixperimatrix

Identifiers

PMID36000040
PMCPMC9392411
OpenAlexW4284891984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.